- Anstee Q.M.
- Targher G.
- Day C.P.
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.Nat. Rev. Gastroenterol. Hepatol. 2013; 10: 330-344
NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.Am. J. Gastroenterol. 2009; 104: 861-867
Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men.Diabetes Care. 2007; 30: 2940-2944
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients.Diabetes Care. 2007; 30: 2119-2121
Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: evidence from the Dongfeng-Tongji cohort study.PLoS One. 2017; 12e0174291
Nonalcoholic fatty liver disease–a risk factor for microalbuminuria in type 2 diabetic patients.Rom. J. Intern. Med. 2009; 47: 55-59
Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non‐alcoholic fatty liver disease.J. Diabetes Investig. 2014; 5: 170-175
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients.Diabetologia. 2010; 53: 1341-1348
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.Diabetologia. 2008; 51: 444-450
- Targher G.
- Lonardo A.
- Byrne C.D.
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.Nat. Rev. Endocrinol. 2018; 14: 99
- American Diabetes Association
Diagnosis and classification of diabetes mellitus.Diabetes Care. 2013; 36: S67-S74
Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population.Diabetol. Metab. Syndr. 2010; 2: 1
Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case–control study.Metabolism. 2015; 64: 527-538
Assessment of serum 25-hydroxy vitamin D improves coronary heart disease risk stratification in patients with type 2 diabetes.Am. Heart J. 2015; 170 ()
Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes.Atherosclerosis. 2016; 254: 42-51
Association of Peripheral 5-HYDROXYINDOLE-3-ACETIC acid, a serotonin derivative, with Metabolic Syndrome and LOW-GRADE Inflammation.Endocr. Pract. 2015; 21: 711-718
Serum 25-hydroxyvitamin D, non-alcoholic fatty liver disease and type 2 diabetes.Nutr. Metab. Cardiovasc. Dis. 2017; 27: 93-95https://doi.org/10.1016/j.numecd.2016.09.008
The diagnosis and management of non‐alcoholic fatty liver disease: practice guideline by the american association for the study of liver diseases, american college of gastroenterology, and the american gastroenterological association.Hepatology. 2012; 55: 2005-2023
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia. 1985; 28: 412-419
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.Clin. Chem. 2007; 53: 766-772
IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 C. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase.Clin. Chem. Lab. Med. 2002; 40: 718-724
Consensus of DGKL and VDGH for interim reference intervals on enzymes in serum Konsensus von DGKL und VDGH zu vorläufigen Referenzbereichen für Serumenzyme.LaboratoriumsMedizin. 2005; 29: 301-308
- Early Treatment Diabetic Retinopathy Study Research Group
Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification: ETDRS report number 10.Ophthalmology. 1991; 98: 786-806
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.Ophthalmology. 2003; 110: 1677-1682
Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.Annales d’endocrinologie. Elsevier Masson,
Diabetic kidney disease: a report from an ADA Consensus Conference.Am. J. Kidney Dis. 2014; 64: 510-533
Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score.Diabet. Med. 2002; 19: 962-965
A Comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy.Int. J. Diabetes Dev. 2010; 30: 43
- Bugianesi E.
- McCullough A.J.
- Marchesini G.
Insulin resistance: a metabolic pathway to chronic liver disease.Hepatology. 2005; 42: 987-1000
- Chatrath H.
- Vuppalanchi R.
- Chalasani N.
Dyslipidemia in Patients With Nonalcoholic Fatty Liver Disease. In Seminars in Liver Disease. Thieme Medical Publishers,
- Buzzetti E.
- Pinzani M.
- Tsochatzis E.A.
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).Metabolism. 2016; 65: 1038-1048
IL-1 cytokine family members and NAFLD: neglected in metabolic liver inflammation.J. Hepatol. 2011; 55: 960-962
Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease.J. Am. Soc. Nephrol. 2008; 19: 1564-1570
Impact of non‐alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes.Intern. Med. J. 2010; 40: 437-442
An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes.J. Diabetes Complicat. 2015; 29: 1240-1247
The relationship between nonalcoholic fatty liver disease and retinopathy in NHANES III.PLoS One. 2016; 11 ()
Assessment of the relationship between non‐alcoholic fatty liver disease and diabetic complications.J. Diabetes Investig. 2016;
Relationship between β-cell function, metabolic control, and microvascular complications in type 2 diabetes mellitus.Diabetes Technol. Ther. 2015; 17: 29-34
Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients.Acta Diabetol. 2012; 49: 9-15
Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.World J. Gastroenterol. 2013; 19: 3134-3142
Analysis of the effect of diabetes type 2 duration on beta cell secretory function and insulin resistance.Srp. Arh. Celok. Lek. 2005; 134: 219-223
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Diabetes Care. 2011; 34: 1139-1144
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.Clin. Biochem. 2009; 42: 1331-1346